Episode 214: High-Dose CBD, Hemp-Derived THC, and the Direct-to-Door Cannabis Model with Bellasoft
About this episode
This episode discusses how Bellasoft CBD is addressing the cannabis industry's pricing and dosing issues while expanding their operations.
What happens when a cannabis manufacturer decides to challenge the industry’s biggest problem: products that are overpriced and underdosed? In this episode sponsored by SHOPLINE in association with ICBC and hosted by Mary Jane Gibson on the MJBizCon 2025 show floor, Carl Clouse and Preston Jackson of Bellasoft CBD explain how their Fresno operation expanded from a 500-square-foot startup to a 3,500-square-foot manufacturing facility, while partnering with brands like Dr. Zodiac to produce federally compliant hemp-derived THCA products that can ship directly to consumers in 38 states. WEBSITE: https://cannatechtoday.com/ Make sure to follow our other social media platforms to stay up-to-date on all things Cannabis & Tech Today. https://twitter.com/cannatechtoday https://www.facebook.com/CannaTechToday https://www.instagram.com/cannatechtoday
Sponsors
SHOPLINE
More episodes of Cannabis Tech Talks
- Episode 216: Phoebe AI and the Future of Cannabis Data with Proteus420
- Episode 213: How Calyx Containers Disrupted an Industry
- Episode 212: ‘King Bong’ of LuvBuds on Cannabis’s Trough Period
- Episode 211: Lüt Builds New Payment Rails for Cannabis Commerce
- Episode 210: Solving the Cannabis Contamination Problem with Rad Source's Photonic Technology
- Episode 209: Rethinking Cannabis Quality with CSQ's Darwin Millard
Explore listener stats, chart rankings, contacts and more on the Cannabis Tech Talks podcast page.